Suraj Mudichintala

Suraj Mudichintala

Director/Board Member at Axon Therapies, Inc.

Finance
Consumer Services
Health Technology

Profile

Suraj Mudichintala is a senior associate at APVC in Santa Cruz, CA.
He represents APVC on the Boards of Alpheus Medical, Axon Therapies and Onc.ai.
He was previously an investor at Arboretum Ventures, where he served as a Board observer at Allay Therapeutics, Avation Medical, Francis Medical, Health Scholars, Koya Medical, and RareCyte.
Prior to investing, Suraj was an associate with L.E.K.
Consulting, a global strategy consulting firm.
While at L.E.K., Suraj completed ~20 engagements predominantly for life sciences and private equity clients.
Suraj graduated cum laude with a B.S.
in Finance and Analytics from Boston College.
Suraj previously served on the Michigan Translational Research and Commercialization (MTRAC) Oversight Committee for Medical Devices, where he provided guidance to Michigan higher education researchers on transitioning their early stage products to the private sector for commercialization.

Suraj Mudichintala active positions

CompaniesPositionStart
Private Equity Analyst 2017-12-31
Private Equity Analyst 2022-05-31
Director/Board Member -
Director/Board Member -
Director/Board Member -
All active positions of Suraj Mudichintala

Training of Suraj Mudichintala

Wallace E Carroll School of Management Undergraduate Degree
Boston College Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Suraj Mudichintala's experience

Connections

98

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies5

Finance

Finance

Health Technology

Health Services

Technology Services

See company connections
  1. Stock Market
  2. Insiders
  3. Suraj Mudichintala
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW